These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 28115486)

  • 1. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.
    Giorgi M; Melchiorri G; Nuccetelli V; D'Angelo V; Martorana A; Sorge R; Castelli V; Bernardi G; Sancesario G
    Neurobiol Dis; 2011 Jul; 43(1):293-303. PubMed ID: 21515371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A.
    Strick CA; James LC; Fox CB; Seeger TF; Menniti FS; Schmidt CJ
    Neuropharmacology; 2010 Feb; 58(2):444-51. PubMed ID: 19765598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
    Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A2A Receptor Dysregulation in Dystonia DYT1 Knock-Out Mice.
    D'Angelo V; Giorgi M; Paldino E; Cardarelli S; Fusco FR; Saverioni I; Sorge R; Martella G; Biagioni S; Mercuri NB; Pisani A; Sancesario G
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.
    Threlfell S; Sammut S; Menniti FS; Schmidt CJ; West AR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):785-95. PubMed ID: 19056933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
    Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
    Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
    Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM
    Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.
    Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A
    Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Transgenic Mouse Model to Investigate the Cell-Autonomous Effects of torsinA(ΔE) Expression in Striatal Output Neurons.
    Gonzalez-Alegre P; Beauvais G; Martin J; Koch RJ; Walker RH; Patel JC; Rice ME; Ehrlich ME
    Neuroscience; 2019 Dec; 422():1-11. PubMed ID: 31669362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
    Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
    Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease.
    Miller S; Hill Della Puppa G; Reidling J; Marcora E; Thompson LM; Treanor J
    J Huntingtons Dis; 2014; 3(4):333-41. PubMed ID: 25575954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
    Hebb AL; Robertson HA; Denovan-Wright EM
    Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.
    Niccolini F; Mencacci NE; Yousaf T; Rabiner EA; Salpietro V; Pagano G; Balint B; Efthymiou S; Houlden H; Gunn RN; Wood N; Bhatia KP; Politis M
    Mov Disord; 2018 Dec; 33(12):1961-1965. PubMed ID: 30345538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of PDE10A in the rat brain.
    Seeger TF; Bartlett B; Coskran TM; Culp JS; James LC; Krull DL; Lanfear J; Ryan AM; Schmidt CJ; Strick CA; Varghese AH; Williams RD; Wylie PG; Menniti FS
    Brain Res; 2003 Sep; 985(2):113-26. PubMed ID: 12967715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
    Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
    Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 10A in the rat pineal gland: localization, daily and seasonal regulation of expression and influence on signal transduction.
    Spiwoks-Becker I; Wolloscheck T; Rickes O; Kelleher DK; Rohleder N; Weyer V; Spessert R
    Neuroendocrinology; 2011; 94(2):113-23. PubMed ID: 21474921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PDE10A inhibitor, papaverine, differentially activates ERK in male and female rat striatal slices.
    Hsu YT; Liao G; Bi X; Oka T; Tamura S; Baudry M
    Neuropharmacology; 2011 Dec; 61(8):1275-81. PubMed ID: 21816164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
    Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-32.
    Polito M; Guiot E; Gangarossa G; Longueville S; Doulazmi M; Valjent E; Hervé D; Girault JA; Paupardin-Tritsch D; Castro LR; Vincent P
    eNeuro; 2015; 2(4):. PubMed ID: 26465004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.